Ipamorelin is a growth hormone–releasing peptide (GHRP) studied for its ability to stimulate natural growth hormone signaling pathways.

In research environments, Ipamorelin has been examined for its potential influence on recovery processes, metabolic regulation, and tissue maintenance.

Unlike earlier growth hormone secretagogues, Ipamorelin has demonstrated a more selective interaction with growth hormone pathways, which has made it a frequent subject of interest in studies related to hormonal balance and regenerative physiology.